Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables.
Author(s): Bai Y, Tolles J, Cheng H, Siddiqui S, Gopinath A, Pectasides E, Camp RL, Rimm DL, Molinaro AM
Publication: Lab Invest, 2011, Vol. 91, Page 1253-61
PubMed ID: 21519325 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine the effects of cold ischemia time, surgical procedure type, and the analysis of tissue microarrays versus whole tissue sections on quantitative immunofluorescence of proteins and phospho-proteins using AQUA. The median time between acquisition of core needle biopsy and surgical resection was 27.5 days.
Summary of Findings:
When a cohort of 20 paired CNB and SR were examined in a tissue microarray format (AQUA scores from 2 spots for each type of specimen were averaged), no statistically significant differences were seen in the antigenicity of pERK, pAKT, pTyr, ER, p53, or Ki67. However, insignificant decreases in pERK, pAKT, pTyr, and Ki67 were seen for SR compared with CNB. When whole tissue sections were evaluated from a second cohort of 14 matched CNB and SR, pAKT, pERK, ER, cytokeratin, and pS6K1 immunofluorescence was significantly lower in SR (average of 19 20x fields of view) compared to CNB (average of 11 20x fields of view; p<0.05). For ER, the authors report that none of the cases would have changed from an ER-positive status in the CNB to an ER-negative status with the SR. At the same time, total AKT, ERK, S6K1, Ki67, and GAPDH were not affected by surgical procedure type, however the authors subsequently determined their sample size was not large enough to detect total protein epitope differences for AKT, ERK, S6K1, Ki67, and GAPDH.
Biospecimens
Preservative Types
- Formalin
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Immunohistochemistry Protein Tissue microarray Small molecule Immunohistochemistry Morphology Fluorescent microscopy Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Biospecimen Acquisition Cold ischemia time 0 min
1-5 h
Immunohistochemistry Specific Targeted peptide/protein pAKT
AKT
pERK
ERK
pS6K1
S6K1
GAPDH
Ki67
ER
pTyr
p53
Cytokeratin
Biospecimen Aliquots and Components Type of slide Tissue microarray
Whole tissue section
Biospecimen Aliquots and Components Aliquot size/volume Two 1.5 mM tissue microarray cores
An average of 11 20x fields of view
An average of 19 20x fields of view
Biospecimen Acquisition Method of tissue acquisition Core needle biopsy
Surgical resection